India, July 14 -- HeartBeam Inc. (BEAT), announced that the U.S. Patent Office has allowed a new patent covering acoustic sensing and thoracic impedance measurement for its cable-free ECG device.
The patent expands the device to function as a "digital stethoscope" capturing heart valve sounds, while thoracic impedance measurement allows monitoring of fluid buildup in the chest- a key factor in heart failure management. Unlike wrist- or finger-worn wearables, HeartBeam's chest-based device is positioned at the anatomically relevant site for both heart-sound and fluid monitoring.
Heart failure affects nearly 6.7 million adults in the U.S. and is one of the leading causes of hospitalization, with costs estimated at $30,000 per patient annual...